Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.
Source: www.fool.com
This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.